Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

BACKGROUND. The efficacy of adjuvant targeted therapy for operable lung cancer is still under debate. Comprehensive genetic profiling is needed for detecting co‐mutations in resected epidermal growth factor receptor (EGFR)‐mutated lung adenocarcinoma (ADC), which may interfere the efficacy of adjuva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Zhao, Ze‐Rui, Lin, Yao‐Bin, Ng, Calvin S.H., Zhang, Rong, Wu, Xue, Ou, Qiuxiang, Chen, Wendan, Zhou, Wen‐Jie, Lin, Yong‐Bin, Su, Xiao‐Dong, Shao, Yang W., Long, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795151/
https://ncbi.nlm.nih.gov/pubmed/30872465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0567
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados